erlotinib hydrochloride has been researched along with iodine in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (iodine) | Trials (iodine) | Recent Studies (post-2010) (iodine) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 31,575 | 862 | 6,879 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baxa, J; Bejcek, J; Ferda, J; Flohr, T; Krakorova, G; Matouskova, T; Schmidt, B; Sedlmair, M | 1 |
1 other study(ies) available for erlotinib hydrochloride and iodine
| Article | Year |
|---|---|
Dual-Phase Dual-Energy CT in Patients Treated with Erlotinib for Advanced Non-Small Cell Lung Cancer: Possible Benefits of Iodine Quantification in Response Assessment.
Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Female; Humans; Iodine; Lung Neoplasms; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Reproducibility of Results; Tomography, X-Ray Computed | 2016 |